TECHNOPHAGE INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA SA has a total of 14 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Singapore, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PATRYS LTD, CRC FOR BIOPHARMACEUTICAL RESE and BOGOCH SAMUEL.
# | Country | Total Patents | |
---|---|---|---|
#1 | Singapore | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Castanheira Aires Da Silva Frederico Nuno | 9 |
#2 | Ferreira Llorente Grancho Lourenço Sara | 8 |
#3 | Volker Côrte-Real Sofia | 8 |
#4 | Da Silva Albuquerque E Freitas Rui Pedro | 4 |
#5 | Santiago De Oliveira Soraia Rafaela | 4 |
#6 | Fleming Outeiro Tiago | 3 |
#7 | Rico Botas Castanho Miguel Augusto | 3 |
#8 | Rodrigues Leandro Clara Isabel | 3 |
#9 | Correia Canhão Pedro Manuel | 3 |
#10 | Santos Neves Vera Luísa | 3 |
Publication | Filing date | Title |
---|---|---|
EP2962103A2 | Cell-based methods for coupling protein interactions and binding molecule selection and diversification | |
SG10201504605RA | Anti-Tumor Necrosis Factor-Alpha Agents And Uses Thereof | |
SG2014012611A | Antibacterial phage, phage peptides and methods of use thereof |